| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |